23
A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association May 28, 2014 Authors: Hilary Caldarelli BSc MPH Alison Locker BSc MSc Bryna Warshawsky MDCM MHSc CCFP FRCPC

A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

Embed Size (px)

Citation preview

Page 1: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

A Profile of People Who InjectDrugs in London, Ontario

Report on the Public Health Agency of Canada

I-Track Survey, Phase 3

Canadian Public Health AssociationMay 28, 2014

Authors: Hilary Caldarelli BSc MPH

Alison Locker BSc MSc

Bryna Warshawsky MDCM MHSc CCFP FRCPC

Page 2: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

Overview

• Background• Methods• Selected results• Limitations• Summary and local next steps• Acknowledgements

Page 3: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

BACKGROUND

Page 4: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

The Middlesex-London Region

• Population 439,151 (2011 Census)– City of London: 366,151– Remainder of Middlesex County:

73,000

• SW Ontario along the Windsor-Quebec City corridor– Approximately 2 hour drive from Windsor

and Toronto

Page 5: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

What is the I-Track Survey?

• Survey of people who inject drugs developed and led by Public Health Agency of Canada (PHAC) – Behavioural and biological surveillance

• Occurs regularly at sentinel sites– Middlesex-London Health Unit participated

for first time in 2012, during Phase 3 (2010-2012)

Page 6: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

Why is I-Track Important?• Injection drug use is an important risk

factor in acquiring hepatitis C and HIV

• People who use injection drugs are a vulnerable population

• Middlesex-London had a significantly higher incidence of hepatitis C compared to Ontario – 2010: 53.4 per 100,000 population vs. 33.1

per 100,000 in ON

Page 7: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

METHODS

Page 8: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

How were I-Track Survey Participants Interviewed?

• The Health Unit partnered with Regional HIV/AIDS Connection (RHAC)

• Face to face interview– Participants recruited and interviewed

through RHAC needle and syringe exchange program (NEP) in January to February 2012

– Approximately 80 questions in 6 topic areas

Page 9: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

Who Was Eligible to Participate?

• Had injected drugs in the past 6 months

• ≥ 16 years of age

• Able to provide informed consent

• Able to speak English or French

• Had not already participated in Phase 3 of the I-Track survey

Page 10: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

SELECTED I-TRACK SURVEY RESULTS

LONDON, 2012

Page 11: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

Demographics

Sex and Age London NationalParticipants 204 2,687

Male 73.5% 68.2%

Female 26.5% 31.8%

Age (mean) 36 39

Page 12: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

Demographics (cont’d)

Characteristic London National

< $1,000 / month income

43.8% 54.1%

Unstable housing 56.9% 38.7%Incarcerated in past6 months

20.1% 11.5%• Unstable housing and recent incarceration

higher in London sample than national sample

Page 13: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

Selected Drugs Injected in Past 6 Months

Drug LondonPercent (rank)

NationalPercent (rank)

Non-prescribed morphine

75.5% (1) 47.0% (3)

Hydromorphone (Dilaudid)

75.5% (1) 47.2% (2)

Oxycontin / Oxycodone

69.1% (3) 37.7% (4)

Methamphetamine 68.1% (4) Not available

Ritalin 66.2% (5) Not available

Cocaine 58.3% (6) 64.3% (1)

Crack 49.0% (7) 24.8% (6)

Heroin 17.2% (8) 26.7% (5)

Page 14: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

Injection Risk Behaviours Behaviour in past six months

London National

Borrowed needles 19.6% 15.5%

Borrowed any other injection equipment (e.g. water, cookers)

42.9% 34.5%

Lent needles to others 26.6% 15.5%

Lent any other injection equipment

43.6% 33.1%

• Borrowing and lending needles and equipment higher in London sample than national sample

Page 15: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

Hepatitis C and HIV PrevalenceLondon National

Hepatitis C 79.1% 68.0%HIV 5.5% 10.9%Unaware HIV positive

60% (6/10) 21.4%

• London sample has higher hepatitis C prevalence rates, but lower HIV prevalence rates compared to the national sample

Page 16: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

Hepatitis C and HIV Prevalence Rates in I-Track vs. General Canadian Population

Page 17: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

LIMITATIONS, SUMMARY AND LOCAL NEXT STEPS

Page 18: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

Limitations

• Non-random convenience sample– Hard to reach population

• Self-reported– Leveraged existing relationships between

interviewers and participants to minimize social desirability bias

• Other potential biases– Recall, selection

Page 19: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

Summary• Active local population of people

who inject drugs with a high prevalence of hepatitis C and HIV

• Opioid drugs were most commonly injected

• Higher prevalence of injection risk behaviours compared to national sample

Page 20: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

Local Next Steps• Overview of local withdrawal

management services and needle disposal and recovery– Assess NEP services in County area

• Additional reporting on impacts of drug use in Middlesex-London

• Collaborate with municipal and community partners to develop a comprehensive community drug strategy

Page 21: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

Acknowledgements

• Survey participants

• Regional HIV/AIDS Connection (RHAC)

• Public Health Agency of Canada (PHAC)

Page 22: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

Thank you!

Page 23: A Profile of People Who Inject Drugs in London, Ontario Report on the Public Health Agency of Canada I-Track Survey, Phase 3 Canadian Public Health Association

A Profile of People Who InjectDrugs in London, Ontario

Report on the Public Health Agency of Canada

I-Track Survey, Phase 3

Canadian Public Health AssociationMay 28, 2014

Authors: Hilary Caldarelli, BSc MPH

Alison Locker, BSc MSc

Bryna Warshawsky, MDCM MHSc CCFP FRCPC